The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 27, 2020

Filed:

Sep. 28, 2018
Applicant:

Shanghai Clear Fluid Biomedical Science Co., Ltd., Shanghai, CN;

Inventors:

Yinghao Zhang, Shanghai, CN;

Jingpeng Fu, Shanghai, CN;

Jia Wan, Shanghai, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/47 (2006.01); A61P 25/28 (2006.01); C07K 19/00 (2006.01); C12N 15/861 (2006.01); A61K 38/17 (2006.01); C12N 15/85 (2006.01); C12N 5/10 (2006.01); A61K 45/00 (2006.01); A61K 48/00 (2006.01); C12N 15/867 (2006.01);
U.S. Cl.
CPC ...
C07K 14/47 (2013.01); A61K 38/17 (2013.01); A61K 45/00 (2013.01); A61K 48/00 (2013.01); A61P 25/28 (2018.01); C07K 19/00 (2013.01); C12N 5/10 (2013.01); C12N 15/85 (2013.01); C12N 15/861 (2013.01); C12N 15/867 (2013.01);
Abstract

The disclosure of the present application relates to a secretory deleted split hand/split foot 1 (sDSS1) protein, the amino acid sequence thereof, the nucleic acid sequence thereof, and the applications of the same. The sDSS1 protein is a secretory protein from higher primate, and can be detected in human serum and cerebral spinal fluid (CSF). The sDSS1 protein can form conjugate with oxidized protein under nonenzymatic condition or with amyloid-beta (Aβ) polypeptide to reduce formation of Aβ oligomer. The addition of sDSS1 protein to culture medium can shield the cytotoxicity induced by oxidized protein, Aβ oligomer, amylin oligomer and glycosylated protein, so as to protect the cells against these toxoproteins. The sDSS1 protein can prolong survival time of senescence-accelerated mice significantly. The protein can be used to prevent and treat the diseases induced by oxidized protein, glycated protein, Aβ protein accumulation, amylin protein accumulation or excessive formation or accumulation of other pathogenic proteins with similar features, and has important potential in biological medicine.


Find Patent Forward Citations

Loading…